Pharmacological
European drug regulations need to change, say experts
Published in Medical Letter on the CDC and FDA, November 4th, 2007
Licensing of new drugs in Europe is increasingly controlled by the European Medicines Agency (EMEA), yet new drugs have only to show they are equivalent to current treatments rather than show superiority.
This favours the interests of drug companies, say Silvio Garattini and Vittorio Bertele from the Mario Negri Institute for Pharmacological Research in Italy. They believe that new drugs should be required to have some added value to current treatments or be cheaper.
One way to ensure this would be to introduce some...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Biomedicine
Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research - Cancer Vaccines
Baylor Research Institute to Collaborate with Mount Sinai School of Medicine to Develop Therapeutic Cancer Vaccines - HIV/AIDS
HIV-Infected Children in Africa Who Receive Care in Primary Health Care Pediatric Treatment Programs Can Have Good Outcomes - Malaria Vaccines
New Lancet study: Malaria vaccine candidate has promising safety, tolerability profile in infants - West Nile Virus
West Nile Virus' Spread Through Nerve Cells Linked to Serious Complication - Acute Promyelocytic Leukemia
INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designation for Tamibarotene for the Treatment of Acute Promyelocytic Leukemia - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
